Rici Healthcare Holdings Limited

HKEX:1526.HK

1.11 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q22022 Q22021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q4
Revenue 1,708.3491,284.34804.538999.5331,341.93583.261,023.273702.933827.686546.25644.268435.881545.333390.05501.423301.373200.699149.438149.438149.438149.438122.23122.23122.23122.23
Cost of Revenue 942.873800.307642.582726.927803.233541.293689.98552.244544.491443.242374.643304.352302.706278.546283.069239.684130.688102.202102.202102.202102.20280.98180.98180.98180.981
Gross Profit 765.476484.033161.956272.606538.69741.967333.293150.689283.195103.008269.625131.529242.627111.504218.35461.68970.01147.23647.23647.23647.23641.24941.24941.24941.249
Gross Profit Ratio 0.4480.3770.2010.2730.4010.0720.3260.2140.3420.1890.4180.3020.4450.2860.4350.2050.3490.3160.3160.3160.3160.3370.3370.3370.337
Reseach & Development Expenses 0000000000000000000000000
General & Administrative Expenses 123.452100.39397.352112.568173.385120.769164.668140.781183.214145.703187.129105.589123.73276.94474.02177.50737.90729.22129.22129.22129.22117.72417.72417.72417.724
Selling & Marketing Expenses 217.395163.189115.6388.452156.06370.256150.86386.712136.04388.971109.37265.95246.07830.27240.41527.19816.90310.62710.62710.62710.6276.9926.9926.9926.992
SG&A 347.509265.956213.763205.325328.108191.025315.531227.493319.257234.674296.601171.541169.91107.216114.486104.75554.8139.84739.84739.84739.84724.71524.71524.71524.715
Other Expenses 0000000000000000-3.127-1.371-1.371-1.371-1.371-1.331-1.331-1.331-1.331
Operating Expenses 341.835245.297200.902199.82340.532189.817294.266210.602298.723233.467312.933178.261139.731103.792104.016104.40651.68438.47638.47638.47638.47623.38423.38423.38423.384
Operating Income 429.892227.649-46.91476.548215.334-138.97630.673-72.571-27.099-128.153-24.458-32.43282.6088.383115.548-41.77717.9838.6998.6998.6998.69917.10117.10117.10117.101
Operating Income Ratio 0.2520.177-0.0580.0770.16-0.2380.03-0.103-0.033-0.235-0.038-0.0740.1510.0210.23-0.1390.090.0580.0580.0580.0580.140.140.140.14
Total Other Income Expenses Net -64.197-47.712-48.267-80.938-98.881-86.3-68.565-57.785-6.395-14.1-29.115-22.90910.636-10.645-9.837-14.347-5.586-7.215-7.215-7.215-7.215-4.894-4.894-4.894-4.894
Income Before Tax 365.695179.937-95.181-4.39116.453-225.276-37.892-130.356-33.494-142.253-53.573-55.34193.244-2.262105.711-56.12412.3971.4831.4831.4831.48312.20712.20712.20712.207
Income Before Tax Ratio 0.2140.14-0.118-0.0040.087-0.386-0.037-0.185-0.04-0.26-0.083-0.1270.171-0.0060.211-0.1860.0620.010.010.010.010.10.10.10.1
Income Tax Expense 89.93953.71820.73725.66841.26324.93715.48513.23510.17929.2912.1414.09326.6969.89728.8488.3775.1180.0660.0660.0660.0662.2442.2442.2442.244
Net Income 240.433123.37-23.74510.46156.221-164.097-8.922-60.24114.044-67.88-22.726-39.4469.726-10.80276.011-47.0297.2791.4171.4171.4171.4179.9649.9649.9649.964
Net Income Ratio 0.1410.096-0.030.010.116-0.281-0.009-0.0860.017-0.124-0.035-0.090.128-0.0280.152-0.1560.0360.0090.0090.0090.0090.0820.0820.0820.082
EPS 0.150.078-0.0150.0070.098-0.1-0.006-0.0380.006-0.043-0.02-0.0250.045-0.0090.054-0.0390.0050.0010.0010.0010.0010.0060.0060.0060.006
EPS Diluted 0.150.078-0.0150.0070.098-0.1-0.006-0.0380.009-0.043-0.014-0.0240.048-0.0090.057-0.0390.0050.0010.0010.0010.0010.0060.0060.0060.006
EBITDA 519.169310.81443.538159.991296.752-62.003111.037-2.82434.207-67.34917.5126.707122.73248.306153.506-11.81835.19821.45221.45221.45221.45228.86228.86228.86228.862
EBITDA Ratio 0.3040.2420.0540.160.221-0.1060.109-0.0040.041-0.1230.0270.0150.2250.1240.306-0.0390.1750.1440.1440.1440.1440.2360.2360.2360.236